Overexpression of soluble human thymosin alpha 1 in Escherichia coli

Acta Biochimica et Biophysica Sinica

Volumn 37, Issue 2, 2005, Pages 147-151

  Chen, Pei Fu ^a   Zhang, Hong Ying ^a   Fu, Geng Feng ^a   Xu, Gen Xing ^a   Hou, Ya Yi ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

Escherichia coli; Fusion expression; Human thymosin alpha 1; Ni2+ affinity chromatography

Indexed keywords

BACTERIAL PROTEIN; HYBRID PROTEIN; NICKEL; THYMOSIN ALPHA1;

AFFINITY CHROMATOGRAPHY; ARTICLE; BACTERIAL STRAIN; COMPARATIVE STUDY; CONTROLLED STUDY; ESCHERICHIA COLI; GENE EXPRESSION; GENE EXPRESSION SYSTEM; NONHUMAN; PLASMID; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; PROTEIN PURIFICATION; SOLUBILITY;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 18844396661     PISSN: 05829879     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1745-7270.2005.00014.x     Document Type: Article

References (28)

1. Goldstein AL, Low TL, McAdoo M, McClure J, Thurman GB, Rossio J, Lai CY et al. Thymosin α1: Isolation and sequence analysis of an immunologically active thymic polypeptide. Proc Natl Acad Sci USA, 1977, 74: 725-729
2. Low TLK, Thurman GB, McAdoo M, McClure J, Rossio JL, Naylor PH, Goldstein AL. The chemistry and biology of thymosin. I. Isolation and characterization and biological activities of thymosin α1 and polypeptide β1 from calf thymus. J Biol Chem, 1979, 254: 981-986
3. Sarandeses CS, Covelo G, Díaz-Jullien C, Freire M. Prothymosin α is processed to thymosin αl and thymosin α11 by a lysosomal asparaginyl endopeptidase. J Biol Chem, 2003, 278: 13286-13293
4. Leichtling KD, Serrate SA, Sztein MB. Thymosin alpha 1 modulates the expression of high affinity interleukin-2 receptors on normal human lymphocytes. Int J Immunopharmacol, 1990, 12: 19-29
5. + cells in an in vitro thymic epithelia organ coculture model. Int J Immunopharmacol, 1999, 21: 15-26
6. Moshier JA, Mutchnick MG, Dosescu J, Holtz TK, Akkary S, Mahakala K, Merline JR et al. Thymosin-α1 but not interferon-α, specifically inhibits anchorage-independent growth of hepatitis B viral transfected HepG2 cells. Heptol, 1996, 25: 814-820
7. Bianco-Batlles D, Naylor CW, Moshier JA, Dosescu J, Naylor PH. Clonal growth inhibition as a bioassay for thymosin alpha 1: Inactivation of Tα1 by trifluroacetic acid. Cell Mol Biol, 2001, 47: 157-160
8. + thymocytes through the activation of cAMP and protein kinase C dependent second messenger pathways. Mechanism of Ageing and Development, 1997, 94: 85-101
9. Roy R, Singh SM, Shanker A. Mechanism of thymocyte apoptosis induced by serum of tumor-bearing host: The molecular events involved and their inhibition by thymosin α-1. Int J Immunopharmacol, 2000, 22: 309-321
10. 1 application augments immune response and down-regulates tumor weight and organ colonization in BALB/c-mice. Cancer Lett, 2000, 159: 9-13
11. Moody TW, Fagarasan M, Zia F, Cesnjaj M, Goldstein AL. Thymosin alpha 1 down-regulates the growth of human non-small cell lung cancer cells in vitro and in vivo. Cancer Res, 1993, 53: 5214-8
12. Giuliani C, Napolitano G, Mastino A, di Vincenzo S, D'Agostini C, Grelli S, Bucci I et al. Thymosin-α regulates MHC class I expression in FRTL-5 cells at transcriptional level. Eur J Immunol, 2000, 30: 778-786
13. Tzehoval E, Sztein MB, Goldstein AL. Thymosins alpha 1 and beta 4 potentiate the antigen-presenting capacity of macrophages. Immunopharmacology, 1989, 18: 107-113
14. Paul S, Sodhi A, Biswas SK. Activation of murine bone-marrow derived macrophages in vitro with thymosin-alpha-1 to tumoricidal state: A comparative study on normal and tumour-bearing hosts. Int J Immunopathol Pharmacol, 2000, 13: 129-140
15. Shrivastava P, Singh SM, Singh N. Activation of tumor-associated macrophages by thymosin alpha 1. Int J Immunopathol Pharmacol, 2004, 17: 39-47
16. Huang Y, Chen Z, Zhou C, Yao H, Li M, Xu C. The modulation of thymosin alpha 1 in the maturation, differentiation and function of murine bone marrow-derived dendritic cells in the absence or presence of tumor necrosis factor-α. Int Immunopharmacol, 2004, 4(4): 539-546
17. Hadden JW. Thymic Endocrinology. Annals of the New York Academy of Sciences, 1998, 840: 352-358
18. Ancell CD, Phipps J, Young L. Thymosin alpha 1. Am J Health Syst Pharm, 2001, 58: 879-885
19. Billich A. Thymosin alpha 1. SciClone Pharmaceuticals. Current Opin Investig Drugs, 2002, 3: 698-707
20. Moscarella S, Buzzelli G, Romanelli RG, Monti M, Giannini C, Careccia G et al. Interferon and thymosin combination therapy in naïve patients with chronic hepatitis C: Preliminary results. Liver, 1998, 18: 366-369
21. Rasi G, Pierimarchi P, Sinibaldi-Vallebona P, Colella F, Garaci E. Combination therapy in the treatment of chronic viral hepatitis and prevention of hepatocellular carcinoma. Int J Immunopharmacol, 2003, 3: 1169-1176
22. 1 in combination with cytokines and chemotherapy for the treatment of cancer. Int J Immunopharmacol, 2003, 3: 1145-1150
23. Garaci E, Pica F, Rasi G, Favalli C. Thymosin alpha 1 in the treatment of cancer: From basic research to clinical application. Int J Immunopharmacol, 2000, 22: 1067-1076
24. Hadden JW. Immunodeficiency and cancer: Prospects for correction. Int Immunopharmacol, 2003, 3: 1061-1071
25. Wetzel R, Heyneker HL, Goeddel DV, Jhurani P, Shapiro J, Crea R, Low TL et al. Production of biologically active N alpha-desacetylthymosin alpha 1 in Escherichia coli through expression of a chemically synthesized gene. Biochemistry, 1980, 19: 6096-6104
26. Shmelev VA, Bunina ZF, Kudriavtseva TIu, Zinchenko EV, Boldyreva EF, Korobko VG. Isolation of a group of hybrid proteins consisting of tumor necrosis factor alpha and thymosin alpha 1. Mol Gen Mikrobiol Virusol, 1995, (1): 9-14
27. Xiu ZY, Yu Y, Chen CQ. Fusion expression of human thymosin alpha 1 in Escherichia coli. Sheng Wu Gong Cheng Xue Bao, 2002, 18: 541-545
28. Zhang J, Qin Y, Ou-Yang Q, Xu H, Zhou KF, Liu RH, Lou SL. Construction of shuttle expression vector and expression of thymosin α1 in Synechococcus sp. PCC7942. Shi Yan Sheng Wu Xue Bao, 2003, 36: 1-4